Tatva Chintan IPO: Parvati Rai of KRChoksey explains why the issue got fully subscribed within hours

Tatva Chintan IPO: Parvati Rai of KRChoksey explains why the issue got fully subscribed within hours
Moneycontrol
4 hours ago
Sunil Matkar
© Sunil Matkar
Tatva Chintan IPO: Parvati Rai of KRChoksey explains why the issue got fully subscribed within hours
The initial public offering (IPO) of Tatva Chintan Pharma Chem opened for subscription on July 16 and was fully subscribed within the initial hours.
As the IPO momentum remains strong, specialty chemicals space has in particular caught investor fancy. Of the key factors playing out, global de-risking of the supply chain away from China holds remarkable promise for Indian companies. Fundamentally strong companies in the sector which went public recently have delivered sound returns. Rossari Biotech and Laxmi Organics have clocked more than 100 percent returns since listing.

Related Keywords

China ,India ,Netherlands ,Tatva Chintan Pharma ,Parvati Rai ,Tatva Chintan ,Sunil Matkar Tatva Chintan , ,Tatva Chintan Pharma Chem ,Laxmi Organics ,Chintan Pharma Chem ,சீனா ,இந்தியா ,நெதர்லாந்து ,தத்வா சிந்தன் பார்மா ,பார்வதி ராய் ,தத்வா சிந்தன் ,தத்வா சிந்தன் பார்மா செம் ,லக்ஷ்மி ஆர்க்யாநிக்ஸ் ,சிந்தன் பார்மா செம் ,